Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen David Prior Insider Profile
4 Followers
Stephen David Prior, CSO at AN2 Therapeutics, Inc., holds 33.31K shares in AN2 Therapeutics, Inc. (Ticker: ANTX). Most recently, Stephen David Prior Sold $2,029 shares of AN2 Therapeutics, Inc. on Jan 07, 2025 for an estimated value of 2.72K.
Stephen David Prior has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Stephen David Prior's holdings
Insider Roles
CSO
Roles that Stephen David Prior holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stephen David Prior
Stephen David Prior's Trading History
List of latest transactions for each holding click on a transaction to see Stephen David Prior's performance on stock
You May Also Like
Stephen David Prior insider profile FAQ
What is the percentage of profitable transactions made by Stephen David Prior?
The percentage of profitable transactions made by Stephen David Prior is ―.
What is the average return per transaction made by Stephen David Prior?
The average return per transaction made by Stephen David Prior is ―.
What stocks does Stephen David Prior hold?
Stephen David Prior holds: ANTX stocks.
What was Stephen David Prior’s latest transaction?
Stephen David Prior latest transaction was an Informative Sell of $2.72K.
What was Stephen David Prior's most profitable transaction?
Stephen David Prior’s most profitable transaction was an Informative Sell of ANTX stock on January 7, 2025. The return on the trade was 7.40%.
What is Stephen David Prior's role in AN2 Therapeutics, Inc.?
Stephen David Prior's role in AN2 Therapeutics, Inc. is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.